Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver (Q61848136)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

breast carcinoma metastatic to the liver

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

2

Razelle Kurzrock

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Alex Cheung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Sanjay Gupta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Giora Mavligit

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Diane F Barber

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

David C Madoff

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Michael J Wallace

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

E Edmund Kim

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Steven A Curley

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Gabriel N Hortobagyi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

English

0 references

publication date

1 June 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

109

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

2190-2196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

Prognostic factors for patients with hepatic metastases from breast cancer

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Prognostic significance of liver metastases as first site of generalisation in patients with breast cancer--a retrospective analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Pharmacologic rationale for regional drug delivery.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

The taxanes: an update

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Hepatic artery administration of paclitaxel.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Synthesis of taxoids with improved cytotoxicity and solubility for use in tumor-specific delivery

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Initial paclitaxel improves outcome compared with CMFP combination chemotherapy as front-line therapy in untreated metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Hepatic arterial infusion of paclitaxel for liver metastasis from gastric cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Percutaneous hepatic arterial infusion of cisplatin-vinblastine for refractory breast carcinoma metastatic to the liver

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Hepatic arterial infusion after liver resection

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Is there a new drug beyond floxuridine for intra-arterial hepatic chemotherapy in liver metastases from colorectal cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22672

7 January 2021

Identifiers

DOI

10.1002/CNCR.22672

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17464952%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference